Suboxone
Daily buprenorphine-naloxone treatment is often the practical starting or maintenance path for opioid use disorder care.
Suboxone, Sublocade, and Vivitrol answer different treatment questions. Suboxone and Sublocade are buprenorphine-based options, while Vivitrol is extended-release naltrexone and requires opioid-free planning before treatment.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
Approved addiction medicines have specific indications and different starting requirements. A medicine used for opioids is not automatically suitable for alcohol, stimulants, cannabis or gambling. The evaluation matches the diagnosed disorder, treatment goal and health history to the options.
OUD options include buprenorphine, methadone and naltrexone pathways. AUD options include naltrexone, acamprosate and disulfiram. Tobacco treatment has a different group of medicines. Stimulant and cannabis use disorders do not have an FDA-approved medication, although selected off-label treatment may be discussed.
Consider daily versus administered medication, kidney and liver health, opioid exposure, withdrawal, interactions, monitoring and the actual access pathway. Price or visit frequency alone does not decide suitability.
Treatment for opioid use disorder starts with an assessment of opioid use, withdrawal, overdose risk and what you want to change. Medicines can reduce withdrawal or cravings and help protect recovery. Treatment can be appropriate after heroin, fentanyl, nonprescribed pills or problematic prescription opioid use. An evaluation is still useful if you are uncertain about the diagnosis or have returned to use after earlier treatment.
The clinician reviews frequency and route of use, loss of control, consequences, tolerance and withdrawal, while distinguishing prescribed use and physical dependence from OUD. Pregnancy, severe symptoms, intoxication, other substance use and health conditions affect the safest setting. Bring any current OUD prescription: transferring care does not necessarily mean starting over, but records and an assessment are needed.
Describe the last opioid use, uncertain pill contents, prior overdoses and current symptoms. Include alcohol, sedatives, stimulants and pain treatment. The clinician assesses whether an outpatient plan is safe or whether urgent, hospital or another level of care is needed. An overdose or unstable condition should not wait for an ordinary clinic appointment.
Compare buprenorphine, methadone and naltrexone against your clinical needs and preferences. Buprenorphine initiation needs a safe plan after recent opioid exposure. Methadone for OUD generally requires an opioid treatment program. Naltrexone requires detoxification and opioid-free assessment. A clinic should help with a suitable referral when the chosen treatment is outside its verified services.
Clarify formulation, pharmacy or injection logistics, return visits, monitoring and whom to call for access problems. Address pain and mental-health treatment at the same time. Discuss counseling, recovery support and barriers such as transportation, housing or work hours without assuming one service can provide every resource.
Have naloxone and an overdose-response plan. Identify what to do after missed medication, renewed use or hospital discharge. A return to use needs reassessment of symptoms, dose coverage and other risks; it should not be hidden because you fear the visit will be wasted.
Bring identification if required for registration, a medication list, pharmacy details, recent treatment records and relevant insurance information. Tell the clinician if you are nearly out of medication or cannot obtain it. Ask how the first prescription or injection is arranged and what follow-up is required. Do not take borrowed treatment or create an opioid-free interval without advice to prepare for the visit.
Call 911 for possible overdose, slow breathing, unresponsiveness, severe chest pain or collapse. Use available naloxone for suspected opioid overdose and follow the product instructions. Alcohol and sedatives can sharply increase risk with opioids or OUD medicines. After a period without opioids, tolerance can be lower, making return to previous use especially dangerous. Pregnancy, dehydration or uncontrolled withdrawal can require urgent assessment.
Ongoing visits review withdrawal, craving patterns, substance use, function and medication effects. Testing, when clinically appropriate, should help interpret the treatment picture; it is not a complete diagnosis by itself. Discuss whether the plan needs more support, a different formulation or another treatment setting. Effective medication may continue for a long time. Stopping requires a plan for relapse prevention and overdose safety.
Ask what the service actually provides: evaluation, ongoing prescribing, injections, counseling or referral. Confirm the specific location, appointment availability, fees and pharmacy or payer requirements. Same-day availability depends on assessment, the intended service and supply. If the requested medicine is unavailable, ask for a safe interim or referral plan rather than waiting without a next step.
Sublocade is a long-acting buprenorphine injection for moderate to severe opioid use disorder. A clinician gives it under the skin; you do not take it home or inject it yourself. It can replace the daily task of taking a buprenorphine film or tablet for some patients. The decision also depends on withdrawal risk, your response to buprenorphine, health history and whether you can return for ongoing care.
Buprenorphine partly activates opioid receptors and can reduce opioid withdrawal and cravings. The injection forms a depot that releases medicine over time. It is still an opioid medicine and can cause physical dependence. Its long action may help with medication routines, but it also means a dose cannot be quickly adjusted after an injection.
The evaluation first confirms opioid use disorder and reviews recent fentanyl, heroin, pain-pill, methadone and buprenorphine use. Some patients already taking transmucosal buprenorphine can transition directly. Patients who are new to buprenorphine need a supervised first dose and assessment of tolerability. Pregnancy, liver disease, breathing problems and sedating medicines require an individualized discussion; moderate or severe liver impairment can make this depot unsuitable.
Naltrexone blocks opioid receptors; it is different from buprenorphine, which partially activates them. Starting naltrexone while physically dependent on opioids can cause severe precipitated withdrawal. Vivitrol generally requires at least 7–10 opioid-free days after short-acting opioids; people transitioning from buprenorphine or methadone can remain vulnerable for up to two weeks. The clinician verifies readiness and the current label—do not stop opioids or choose a waiting period on your own.
Treatment for opioid use disorder starts with an assessment of opioid use, withdrawal, overdose risk and what you want to change. Medicines can reduce withdrawal or cravings and help protect recovery. Treatment can be appropriate after heroin, fentanyl, nonprescribed pills or problematic prescription opioid use. An evaluation is still useful if you are uncertain about the diagnosis or have returned to use after earlier treatment.
Buprenorphine and methadone activate opioid receptors in controlled ways; naltrexone blocks them and requires an opioid-free starting point. They have different entry requirements and do not offer an identical experience. Naloxone reverses an opioid overdose but is not ongoing OUD treatment. Withdrawal management by itself does not resolve the longer-term risk of relapse and overdose.
The clinician reviews frequency and route of use, loss of control, consequences, tolerance and withdrawal, while distinguishing prescribed use and physical dependence from OUD. Pregnancy, severe symptoms, intoxication, other substance use and health conditions affect the safest setting. Bring any current OUD prescription: transferring care does not necessarily mean starting over, but records and an assessment are needed.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
Daily buprenorphine-naloxone treatment is often the practical starting or maintenance path for opioid use disorder care.
Monthly injectable buprenorphine may fit some patients after buprenorphine treatment is already established and the medication path is coordinated.
Monthly extended-release naltrexone can be used for alcohol dependence and for opioid relapse prevention after opioid detoxification and opioid-free planning.
Naloxone is overdose reversal support and should be discussed separately from the maintenance medication decision.
Bronx
932 E 174th St, Bronx, NY 10460
Local MAT access for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
37-15 23rd Ave, Astoria, NY 11105
Local MAT access for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Bronx
2063A Bartow Ave, Bronx, NY 10475
Local MAT access for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Local MAT access for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Local MAT access for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Local MAT access for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Local MAT access for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
30-07 36th Ave, Astoria, NY 11106
Local MAT access for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Long Island
135 Mineola Blvd, Mineola, NY 11501
Local MAT access for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Manhattan
259 1st Ave, New York, NY 10003
Local MAT access for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Local MAT access for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone careReview online Suboxone treatment options in NYC with Nao Medical, including telemedicine evaluation, insurance review, follow-up planning, and in-person backup when needed.
Find buprenorphine treatment for opioid use disorder in NYC with Nao Medical, including Suboxone care, induction planning, follow-up, insurance review, and local MAT locations.
Review naloxone access, overdose safety planning, and how naloxone fits with opioid addiction treatment, Suboxone, Sublocade, and Vivitrol care at Nao Medical.
Find opioid de-addiction medicine in NYC with Nao Medical, including opioid use disorder assessment, medication options, Suboxone care, naloxone safety planning, and follow-up.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Review opioid treatment optionsNao Medical provides outpatient addiction care. The first visit can focus on the immediate clinical question and medication planning when relevant. When wanted or clinically recommended, the care plan can also include counseling, recovery support, and closer follow-up. Related information: outpatient addiction care.
Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking. Review addiction-treatment insurance support
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.